Financials • Specialty Insurers
$320.73 ▼ -0.90
(-0.28%)
MKT CAP: $29.79B • VOL: 996.8K
52W L $241 52W H $352
WTW // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $9.52B | $9.74B | $9.30B |
| YoY Revenue Growth % | -2.3% | +4.7% | — |
| Gross Profit | $4.19B | $4.29B | $4.09B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.23B | $627.0M | $1.36B |
| Operating Margin % | 23.5% | 6.4% | 14.7% |
| Net Income (GAAP) | $1.60B | -$98.0M | $1.05B |
| EBITDA (Normalized) | $2.58B | $977.6M | $1.70B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.77B | $1.51B | $1.34B |
| Capital Expenditures (CapEx) | $428.2M | $438.3M | $418.7M |
| Free Cash Flow (FCF) | $1.35B | $1.07B | $926.3M |
| FCF Margin % | 14.2% | 11.0% | 10.0% |
| Return on Invested Capital (ROIC %) | 16.6% | 4.4% | 10.9% |
| Cash & Short-Term Equivalents | $3.13B | $1.89B | $1.80B |
| Total Debt (Short + Long Term) | $5.76B | $5.31B | $3.83B |
| Total Stockholders' Equity | $7.98B | $7.94B | $7.86B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR WTW.